
Travotis (Travoprost 0.004%) increases aqueous outflow and lowers intraocular pressure by 25–32% with a convenient once-daily dosage.
It is a first-line therapy for ocular hypertension and open-angle glaucoma.
Key Highlights
- Lowers IOP by 25–32%
- Increases aqueous outflow
- Once-daily dosage
Indications
Ocular hypertensionOpen-angle glaucoma


